Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01498224
Other study ID # OTX-11-002
Secondary ID
Status Completed
Phase Phase 3
First received December 18, 2011
Last updated December 8, 2016
Start date December 2011
Est. completion date November 2012

Study information

Verified date February 2016
Source Ocular Therapeutix, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

This is a randomized multicenter study to evaluate the safety and effectiveness of ReSure Sealant compared to sutures for preventing incision leakage within the first 7 days of cataract surgery.


Recruitment information / eligibility

Status Completed
Enrollment 488
Est. completion date November 2012
Est. primary completion date November 2012
Accepts healthy volunteers No
Gender Both
Age group 22 Years and older
Eligibility Inclusion Criteria:

- Subject has a cataract and is expected to undergo clear cornea cataract surgery with phacoemulsification and implantation of posterior chamber intraocular lens

- Subject must be 22 years of age or older

Exclusion Criteria:

- Any intraocular inflammation in study eye or presence of ocular pain in operative eye at preoperative assessment

- Previous corneal or retinal surgery or planned multiple procedures during cataract surgery.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
ReSure Sealant
Comparison of ReSure Sealant to suture(s)
Procedure:
Sutures


Locations

Country Name City State
United States Levenson Eye Associates Jacksonville Florida

Sponsors (1)

Lead Sponsor Collaborator
Ocular Therapeutix, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Presence of ReSure Sealant or suture(s) Presence of ReSure Sealant or suture(s)at every follow-up visit Day 28 Yes
Other Presence of blue colorant in ReSure Sealant Presence of blue colorant in ReSure Sealant at every follow-up visit Day 28 Yes
Other Device ease of use Device ease of use during application Day 0 No
Other Corneal edema at 1 day Corneal edema at 1 day (moderate to severe stromal edema) Day 1 Yes
Other Anterior chamber inflammation Anterior chamber inflammation (defined as greater than or equal to grade 2+ anterior chamber cells) at day 1 Day 1 Yes
Primary Proportion of eyes with any clear corneal incision/suture leakage as determined by positive Seidel test indicating fluid egress within first 7 days after surgery. Days 1-28 Yes
Secondary Foreign Body Sensation Days 1-28 Yes
Secondary Best corrected visual acuity Best corrected visual acuity worse than 20/40 at day 1 Day 1 No
Secondary Best corrected visual acuity Best corrected visual acuity worse than 20/40 at 28 days Day 28 No

External Links